The Filing Desk

Alto Ingredients

ALTO · Nasdaq · Materials · Financials, fiscal 2016 to 2025

ALTO · Last close · November 13, 2026
$3.66
Value Alto Ingredients yourself

Alto Ingredients' revenue fell 4.9% to $918 million in fiscal 2025. Its operating margin was 0.8%, up from −5.3% a year earlier. Free cash flow was $9 million. The diluted share count rose 3.0%.

ALTO INGREDIENTS, INC. Latest fiscal year ended December 31, 2025 10-K filed March 13, 2026 · 0001213900-26-027687 Updated
Revenue
$918M
4.9%
Operating margin
0.8%
6.1 pts
Net income
$13M
 
Free cash flow
$9M
 
Return on capital
2.5%
15.4 pts
Market cap
$284M
Nov 13 close
P/E
5.6x
On $0.65 EPS, 4 qtrs

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

Charts show fiscal years, from the 10-K filings.

What Alto Ingredients does

Alto Ingredients makes and sells specialty alcohols, fuel ethanol and food and feed ingredients in the United States. It runs five alcohol plants: three in Illinois, one in Oregon and one in Idaho. Its alcohols go into mouthwash, cosmetics, pharmaceuticals, cleaners, alcoholic drinks, paints and fuel. Its ingredient products include dried yeast, corn protein, distillers grains and carbon dioxide, used in animal feed, pet food and food.

The company reports three segments. Pekin production covers the three Illinois plants. Western production covers the Oregon and Idaho plants, including a carbon dioxide plant. Marketing and distribution sells the company's own alcohols and ethanol that other producers make. Its results depend heavily on the prices of corn and natural gas, which it buys, compared with the prices of the alcohols and ingredients it sells. Specialty alcohols for industry and agriculture, food and beverage, and health, home and beauty made up about 11%, 6% and 2% of 2025 sales to customers in those three markets.

The company has about 390 full-time employees. It says it can make 330 million gallons of alcohol a year.

Its biggest risks, as it describes them

  • Swings in the prices of corn and natural gas versus the prices of its alcohols and ingredients, which can push sales below the cost of production.
  • Having to idle or stop plants when market conditions are poor, as it did at its Magic Valley plant.
  • Customers that may pay late, not pay, or seek new prices even under longer-term contracts.
From Alto Ingredients's annual report on Form 10-K, filed March 13, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

From fiscal 2021 to 2025, earnings per share fell 28.4% a year and net income 26.7% a year, as new shares raised the share count by 5% and diluted each share's earnings.

Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments5136303623
Debt incl. finance leases50789110085
Net debt (negative means net cash)−042616461
Net debt to EBITDA−0.0x———1.9x
Debt to equity0.1x0.2x0.3x0.4x0.3x
Interest coverage11.2x−33.6x−3.2x−6.8x0.7x
Current ratio3.3x2.5x2.6x2.6x2.6x
Quick ratio2.5x1.7x1.8x1.8x1.6x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Projections

Project Alto Ingredients' revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.

What Alto Ingredients says to expect

  • Full year 2026: Section 45Z tax creditsThrough our efforts to lower our carbon scores at our Columbia facility and Pekin dry mill, we now expect to generate a minimum of $20 million, net of monetization costs, in 2026.
The company's own words, from its earnings release (Form 8-K, Exhibit 99), filed November 4, 2026. They are its expectations, not ours, and not a forecast or price target from The Filing Desk. Replaced when the next release is out.

Insider trades

Over the 12 months between November 14, 2025 and November 13, 2026, 1 insider bought $361,250 of Alto Ingredients shares on the open market, and none sold any.

Buys and sells by month
US$ millions, open-market purchases (up) and sales (down) by officers, directors and 10% owners in each month.
BoughtSold
DateInsiderTradeSharesPriceValueFiling
Sep 14, 2026Gilbert E NathanDirectorBought10,000$3.93$39,300Form 4
Aug 11, 2026Gilbert E NathanDirectorBought50,000$4.15$207,500Form 4
May 13, 2026Gilbert E NathanDirectorBought5,000$4.45$22,250Form 4
May 12, 2026Gilbert E NathanDirectorBought20,000$4.61$92,200Form 4
Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score5 of 92 of 96 of 9
Rule of 40−9.1%−22.6%−4.0%
Altman Z''−2.66−4.66−3.25
Accruals ratio−10.7%−13.0%0.0%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positiveFailFailPass
Cash from operations is positivePassFailPass
Return on assets rosePassFailPass
Cash from operations exceeds net incomePassPassFail
Debt fell relative to assetsFailFailPass
Current ratio rosePassPassFail
Share count didn't riseFailFailFail
Gross margin rosePassFailPass
Revenue rose relative to assetsFailFailPass
F-score5 of 92 of 96 of 9
Companies that report no gross profit are scored on the other eight.

Compare

Put Alto Ingredients side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
Alto IngredientsFY25−4.9%0.8%0.9%2.5%1.9x6
BalchemFY258.8%20.2%16.7%———Compare
EcovystFY2520.9%9.0%9.7%2.9%1.4x6Compare
IngevityFY25−2.7%35.9%23.4%24.6%2.1x6Compare
Perimeter SolutionsFY2516.4%−30.8%31.9%−10.2%—5Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

10 years of figures

Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue1,6251,6321,5151,4258971,2081,3361,223965918
Revenue growth35.8%0.5%−7.2%−6.0%−37.0%34.7%10.6%−8.4%−21.1%−4.9%
Gross profit546−15−105368−28161035
Research and development——————————
Operating income24−26−52−751040−61−24−527
Net income1−35−60−89−1546−42−28−5913
Diluted EPS (US$)0.00−0.85−1.42−1.90−0.280.61−0.60−0.40−0.820.16
Diluted shares (millions)42434347597272737476
Cash flow
Cash from operations37362−317227622−413
Capital expenditure19211537163830115
Free cash flow1816−14−356510−32−8−159
Dividends paid0000000000
Share buybacks0000001400
Acquisitions030000015007
Stock-based compensation3433333443
Balance sheet at fiscal year end
Cash and short-term investments64502719485136303623
Debt incl. finance leases—2442342469850789110085
Total assets708720660612477485478454401389
Total liabilities290337341385181140170175176144
Shareholders' equity388356319227296345308280225245
Margins and ratios
Gross margin3.4%0.4%−1.0%−0.7%5.9%5.6%−2.1%1.3%1.0%3.8%
Operating margin1.4%−1.6%−3.4%−5.2%1.1%3.3%−4.6%−1.9%−5.3%0.8%
Net margin0.1%−2.1%−4.0%−6.2%−1.7%3.8%−3.1%−2.3%−6.1%1.4%
Free cash flow margin1.1%1.0%−0.9%−2.4%7.3%0.9%−2.4%−0.6%−1.5%0.9%
Rule of 40 (growth + FCF margin)36.9%1.4%−8.1%−8.4%−29.8%35.5%8.2%−9.1%−22.6%−4.0%
Return on capital——−7.4%−12.0%1.9%11.2%−14.0%−5.5%−13.0%2.5%
Return on equity0.4%−9.4%−17.8%−32.6%−5.8%14.4%−12.7%−9.5%−23.4%5.7%
Return on assets0.2%−4.9%−8.7%−14.0%−2.8%9.6%−8.6%−6.0%−13.8%3.4%
Net debt to EBITDA—14.9x——1.2x−0.0x———1.9x
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: Alto Ingredients' Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Alto Ingredients.